To analyze the efficacy, tolerability, toxicity profile, quality of life and pharmaco-economics of adjuvant TAC compared to FAC regimen in hormone receptor-positive breast cancer with more than four involved lymph nodes

U. Batra,Bapsy Pp,K. V. Saini,A. Jain,A. V. Atilli,D Lokanatha,K. S. Babu,K Sanjeevan,Devaraju Cj,G. Anupama

To analyze the efficacy, tolerability, toxicity profile, quality of life and pharmaco-economics of adjuvant TAC compared to FAC regimen in hormone receptor-positive breast cancer with more than four involved lymph nodes

2007

U. Batra
Bapsy Pp
K. V. Saini
A. Jain
A. V. Atilli
D Lokanatha
K. S. Babu
K Sanjeevan
Devaraju Cj
G. Anupama

11043 Aim: To analyze the efficacy, tolerability, toxicity profile, quality of life, survival rates and pharmaco-economics of TAC vs. FAC in women with ER/PR positive breast cancer and >4 involved ...

Keywords:

Regimen
Breast cancer
Cancer research
Lymph
Adjuvant
Hormone receptor
Immunology
Toxicity
Medicine
Tolerability
Oncology
Internal medicine
Quality of life
toxicity profile
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations